Silver Book Fact

Topical capsaicin was found in a meta-analysis to provide a degree of pain relief to some patients with painful neuropathic conditions.

Derry S, Lloyd R, Moore R, McQuay H. Topical Capsaicin for Chronic Neuropathic Pain in Adults. Cochrane Database of Systematic Reviews. 2009; 4. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007393.pub2/otherversions

Reference

Title
Topical Capsaicin for Chronic Neuropathic Pain in Adults
Publication
Cochrane Database of Systematic Reviews
Publication Date
2009
Authors
Derry S, Lloyd R, Moore R, McQuay H
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Nerve growth factor (NGF) has been found to be a major mediator of inflammatory and neuropathic pain and provides a new therapeutic target.  
  • 60% of people with persistent back pain who turned to complementary and alternative medicine perceived a “”great deal”” of benefit.  
  • A meta-analysis of duloxetine, an anti-depressant, found a 50% reduction in pain at 12 weeks for diabetic peripheral neuropathy, and a 50% reduction in pain at 12 weeks for fibromyalgia.  
  • Understanding the role of genetics in pain mechanisms is increasing and the potential now exists to conduct genome-wide screens in model organisms to look for pain-associated genes.  
  • Subthalamic nuclei deep brain stimulation (STN-DBS) raises pain thresholds in Parkinson’s disease patients.